A phase 1 dose‐escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
用户vCB0MD6X0Tag
19天前
44
10
已完结
1. 系统已在2025-12-24 18:32:30对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1002/cncr.35751
文献链接: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.35751
其他信息:
出版社: Wiley
作者: Steven G. DuBois; Chitose Ogawa; Lucas Moreno; Yaël P. Mossé; Matthias Fischer; Anne L. Ryan; Kieuhoa T. Vo; Bram De Wilde; Alba Rubio‐San‐Simon; Margaret E. Macy; Lisa Howell; Suzanne Shusterman; Nadège Corradini; Roberto Luksch; Isabelle Aerts; Jennifer H. Foster; Brian D. Weiss; Chandrasekhar Pamidipati Karthik; Eunice Yuen; Emin Avsar; Julie R. Park; Araz Marachelian
